Stock News

Emerald Advisers Has Boosted Its Portola Pharmaceuticals (PTLA) Holding; As Wells Fargo & Co (WFC) Share Value Declined, Cortland Advisers Raised Stake by $783,200

Cortland Advisers Llc increased its stake in Wells Fargo & Co (WFC) by 0.56% based on its latest 2017Q3 regulatory filing with the SEC. Cortland Advisers Llc bought 14,240 shares as the company’s stock declined 8.66% while stock markets rallied. The institutional investor held 2.56M shares of the major banks company at the end of 2017Q3, valued at $141.23 million, up from 2.55 million at the end of the previous reported quarter. Cortland Advisers Llc who had been investing in Wells Fargo & Co for a number of months, seems to be bullish on the $316.24 billion market cap company. The stock increased 0.42% or $0.27 during the last trading session, reaching $64.22. About 16.52M shares traded. Wells Fargo & Company (NYSE:WFC) has risen 9.67% since January 20, 2017 and is uptrending. It has underperformed by 7.03% the S&P500.

Emerald Advisers Inc increased its stake in Portola Pharmaceuticals Inc (PTLA) by 2.18% based on its latest 2017Q3 regulatory filing with the SEC. Emerald Advisers Inc bought 9,703 shares as the company’s stock rose 22.73% with the market. The institutional investor held 453,921 shares of the health care company at the end of 2017Q3, valued at $24.53 million, up from 444,218 at the end of the previous reported quarter. Emerald Advisers Inc who had been investing in Portola Pharmaceuticals Inc for a number of months, seems to be bullish on the $3.24B market cap company. The stock decreased 0.12% or $0.06 during the last trading session, reaching $49.63. About 648,219 shares traded. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has risen 51.17% since January 20, 2017 and is uptrending. It has outperformed by 34.47% the S&P500.

Emerald Advisers Inc, which manages about $1.71B and $2.46B US Long portfolio, decreased its stake in Maxlinear Inc Class A (NYSE:MXL) by 14,490 shares to 450,150 shares, valued at $10.69 million in 2017Q3, according to the filing. It also reduced its holding in Middleby Corp (NASDAQ:MIDD) by 3,613 shares in the quarter, leaving it with 8,018 shares, and cut its stake in Nexstar Media Group Inc (NASDAQ:NXST).

Since December 15, 2017, it had 0 buys, and 1 sale for $563,950 activity.

Investors sentiment increased to 2.16 in 2017 Q3. Its up 0.85, from 1.31 in 2017Q2. It is positive, as 20 investors sold PTLA shares while 37 reduced holdings. 38 funds opened positions while 85 raised stakes. 56.33 million shares or 15.80% more from 48.64 million shares in 2017Q2 were reported. Sg Americas Securities Limited Co reported 0% stake. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Blackrock stated it has 0.01% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Teacher Retirement Of Texas owns 5,310 shares or 0% of their US portfolio. Hoertkorn Richard Charles invested in 500 shares. Eam Invsts Limited Liability Com holds 0.24% or 33,456 shares. Moreover, Vanguard Grp has 0.01% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 5.24M shares. The Israel-based Sphera Funds Mngmt has invested 1.12% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Century Companies Inc accumulated 51,373 shares or 0% of the stock. Omega Advisors holds 50,000 shares or 0.1% of its portfolio. Victory Cap Mngmt invested in 1,265 shares or 0% of the stock. Neuberger Berman Grp Limited Company owns 23,014 shares for 0% of their portfolio. Hall Laurie J Trustee invested in 0.01% or 190 shares. Harvey Management has 143,730 shares. Focused Wealth Inc owns 125 shares.

Among 6 analysts covering Portola Pharmaceuticals (NASDAQ:PTLA), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Portola Pharmaceuticals had 33 analyst reports since August 5, 2015 according to SRatingsIntel. As per Wednesday, August 10, the company rating was maintained by Citigroup. The firm has “Buy” rating by Goldman Sachs given on Friday, December 1. Oppenheimer maintained the shares of PTLA in report on Friday, August 4 with “Buy” rating. As per Wednesday, December 13, the company rating was maintained by Oppenheimer. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has “Neutral” rating given on Tuesday, May 31 by Credit Suisse. The firm has “Buy” rating given on Wednesday, August 9 by Cowen & Co. The firm has “Buy” rating given on Wednesday, August 5 by Cowen & Co. On Thursday, August 10 the stock rating was maintained by Credit Suisse with “Hold”. On Monday, June 26 the stock rating was maintained by Citigroup with “Buy”. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) earned “Neutral” rating by Goldman Sachs on Monday, March 28.

Cortland Advisers Llc, which manages about $2.18 billion US Long portfolio, decreased its stake in Chevron Corp (NYSE:CVX) by 33,191 shares to 1.19 million shares, valued at $139.56 million in 2017Q3, according to the filing. It also reduced its holding in Toronto (NYSE:TD) by 33,844 shares in the quarter, leaving it with 1.15M shares, and cut its stake in Jpmorgan Chase & Co (NYSE:JPM).

Among 36 analysts covering Wells Fargo & Company (NYSE:WFC), 17 have Buy rating, 5 Sell and 14 Hold. Therefore 47% are positive. Wells Fargo & Company had 118 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Wells Fargo & Company (NYSE:WFC) has “Positive” rating given on Wednesday, January 20 by Susquehanna. The stock has “Buy” rating by S&P Research on Thursday, August 13. The firm earned “Buy” rating on Monday, April 25 by Nomura. As per Friday, November 18, the company rating was downgraded by BMO Capital Markets. On Wednesday, September 2 the stock rating was upgraded by Vetr to “Strong-Buy”. Robert W. Baird maintained the stock with “Buy” rating in Friday, October 6 report. The rating was upgraded by Citigroup on Thursday, January 7 to “Buy”. The rating was maintained by Keefe Bruyette & Woods on Thursday, September 28 with “Buy”. The company was upgraded on Wednesday, July 29 by Guggenheim. As per Monday, October 16, the company rating was maintained by BMO Capital Markets.

Investors sentiment decreased to 0.73 in 2017 Q3. Its down 0.15, from 0.88 in 2017Q2. It dived, as 92 investors sold WFC shares while 725 reduced holdings. 103 funds opened positions while 495 raised stakes. 3.65 billion shares or 0.40% less from 3.66 billion shares in 2017Q2 were reported. Gilman Hill Asset Limited Liability Company has 10,065 shares. Moreover, S&Co has 0.82% invested in Wells Fargo & Company (NYSE:WFC). Sumitomo Mitsui Asset Limited invested 0.52% in Wells Fargo & Company (NYSE:WFC). 5,124 are held by Beaumont Partners Limited Co. Woodmont Invest Counsel Limited Liability reported 1.36% of its portfolio in Wells Fargo & Company (NYSE:WFC). Banque Pictet & Cie Sa holds 0.99% in Wells Fargo & Company (NYSE:WFC) or 792,202 shares. Financial Advantage accumulated 18 shares. King Luther accumulated 1.31 million shares. Glenmede Trust Company Na has 2.14M shares for 0.52% of their portfolio. Norris Perne & French Llp Mi holds 1.1% or 128,614 shares. Washington State Bank accumulated 0.76% or 87,411 shares. Kamunting Street Cap Management Ltd Partnership reported 0.87% in Wells Fargo & Company (NYSE:WFC). Fred Alger reported 0.01% in Wells Fargo & Company (NYSE:WFC). Moreover, Lincoln Capital Ltd has 0.2% invested in Wells Fargo & Company (NYSE:WFC). Pinnacle Advisory invested 0.03% in Wells Fargo & Company (NYSE:WFC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *